Featured News

 

Latest News

RNAi Spray a Game Changer for Crop Protection
RNAi Spray a Game Changer for Crop Protection
News   Jan 16, 2017

"BioClay" could provide an environmentally sustainable alternative to chemicals and pesticides.

READ MORE

Takeda Acquire Ariad For $5.2B
Takeda Acquire Ariad For $5.2B
News   Jan 16, 2017

ARIAD Pharmaceuticals today announced it has entered into a definitive agreement to be acquired by Takeda Pharmaceutical Company.

READ MORE

Enhancing Bone Healing in Diabetics
Enhancing Bone Healing in Diabetics
News   Jan 13, 2017

Researchers from Stanford University have uncovered the reason why diabetes can impair bone healing, and demonstrated the potential of activating skeletal stem cells to overcome this.

READ MORE

Regenerating the Epicardium
Regenerating the Epicardium
News   Jan 13, 2017

Researchers from Penn State have shown that activation of cardiac progenitor cells' Wnt signaling pathway can drive them to become epicardium cells.

READ MORE

Leaf-Inspired Continuous-Flow Photochemistry
Leaf-Inspired Continuous-Flow Photochemistry
News   Jan 13, 2017

Solar-powered photomicroreactor harnesses Sun's energy for continuous flow photoredox reactions.

READ MORE

Amgen And Immatics Collaborate To Develop Cancer Immunotherapies
Amgen And Immatics Collaborate To Develop Cancer Immunotherapies
News   Jan 12, 2017

Amgen and Immatics announce collaboration and exclusive license agreement to develop next-generation, T-cell engaging bispecific immunotherapies targeting multiple cancers.

READ MORE

AGC Acquires CMC Biologics
AGC Acquires CMC Biologics
News   Jan 12, 2017

AGC Asahi Glass - a subsidiary of AGC Group - acquires CMC Biologics for $516m.

READ MORE

U.S. FDA Accepts Licence For Biosimilar Trastuzumab
U.S. FDA Accepts Licence For Biosimilar Trastuzumab
News   Jan 12, 2017

Mylan (UK) and Biocon's (IND) license application for biosimilar to branded trastuzumab for the treatment of HER2-positive breast cancers receives FDA acceptance.

READ MORE

Timing is Everything in Phage Therapy
Timing is Everything in Phage Therapy
News   Jan 12, 2017

Mathematical model sheds light on the timing of key, intracellular events.

READ MORE

Kite And Fosun Establish Joint Venture In China
Kite And Fosun Establish Joint Venture In China
News   Jan 12, 2017

Kite Pharma and Fosun Pharma announce joint venture to develop, manufacture and commercialize Kite's lead product candidate, axicabtagene ciloleucel.

READ MORE